Table 2.
BAFF-R b | BCMA b | TACI b | CD19 b | CD138 b | |
---|---|---|---|---|---|
( n =15) | ( n =15) | ( n =15) | ( n =12) | ( n =12) | |
CD19b | 0.49† | 0.44† | 0.19 | ||
(n =12) | |||||
CD138b | 0.70** | 0.79*** | 0.39 | 0.39 | |
(n =12) | |||||
MX-1c | 0.23 | 0.33 | 0.38† | 0.12 | −0.01 |
(n =15) | |||||
BDCA-2c | 0.16 | 0.42† | 0.23 | 0.37 | 0.54* |
(n =15) |
aBAFF-R, B-cell-activating factor of the tumour necrosis factor family receptor; BCMA, B-cell maturation antigen; BDCA-2, Blood dendritic cell antigen 2; MX-1, Interferon α/β–inducible myxovirus resistance 1 protein; TACI, Transmembrane activator and calcium modulator and cyclophilin ligand interactor. Data included to correlation analysis were: bNumbers of positive cells counted by conventional microscopy per area (n/mm2). Included samples which expressed at least one of the receptors. cQuantitative evaluation of expression by computerised image analysis (percentage of positively stained area). Data are correlation coefficients of Spearman´s rank order test. ***P <0.005, **P <0.01, *P <0.05, † P <0.1.